Belvedere Trading LLC Novartis Ag Call Options Transaction History

Belvedere Trading LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2024 Jan 30, 2025	SELL	$96.78 - $117.18 $19,356 - $23,436	-200 Reduced 0.88%	22,500 $2.19 Million
Q2 2024 Aug 09, 2024	BUY	$92.57 - $107.37 $2.1 Million - $2.44 Million	22,700 New	22,700 $2.42 Million
Q4 2023 Feb 13, 2024	BUY	$92.27 - $101.54 $166,086 - $182,772	1,800 New	1,800 $181,000
Q4 2022 Feb 14, 2023	BUY	$75.55 - $92.52 $302,200 - $370,080	4,000 New	4,000 $362,000

1,430

133M

1.12M

1.82M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $227B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.